Marvel Biosciences Corp's total assets for Q1 2026 were C$683.06K, an increase of 109.07% from the previous quarter. TSE:MRVL total liabilities were C$4.33M for the fiscal quarter, a 0.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.